Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Recordati (REC.MI) has a market cap of $11.98 billion USD. According to our data, Recordati is ranked No.1444 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $11.98 B |
10.18%
|
| Dec 30, 2024 | $10.88 B |
6.16%
|
| Dec 29, 2023 | $10.24 B |
29.35%
|
| Dec 30, 2022 | $7.92 B |
-29.50%
|
| Dec 30, 2021 | $11.23 B |
27.33%
|
| Dec 30, 2020 | $8.82 B |
23.40%
|
| Dec 30, 2019 | $7.15 B |
27.31%
|
| Dec 28, 2018 | $5.62 B |
-15.77%
|
| Dec 29, 2017 | $6.67 B |
40.69%
|
| Dec 30, 2016 | $4.74 B |
14.83%
|
| Dec 31, 2015 | $4.13 B |
92.51%
|
| Dec 30, 2014 | $2.14 B |
26.30%
|
| Dec 30, 2013 | $1.70 B |
56.84%
|
| Dec 28, 2012 | $1.08 B |
30.25%
|
| Dec 30, 2011 | $0.83 B |
-14.63%
|
| Dec 30, 2010 | $0.97 B |
42.22%
|
| Dec 30, 2009 | $0.68 B |
42.51%
|
| Dec 30, 2008 | $0.48 B |
-33.78%
|
| Dec 28, 2007 | $0.73 B |
8.35%
|
| Dec 29, 2006 | $0.67 B |
2.15%
|
| Dec 30, 2005 | $0.66 B |
36.31%
|
| Dec 31, 2004 | $0.48 B |
17.84%
|
| Dec 31, 2003 | $0.41 B |
2.62%
|
| Dec 31, 2002 | $0.40 B |
-30.25%
|
| Dec 31, 2001 | $0.57 B |
-109.91%
|
| Dec 29, 2000 | $-5.75 B |
-104.74%
|
| Dec 31, 1999 | $121.23 B |
-243.88%
|
| Dec 31, 1998 | $-84.26 B |
-101.81%
|
| Dec 31, 1997 | $4.650 T |
-101.37%
|
| Dec 31, 1996 | $-338.447 T |
-101.88%
|
| Dec 29, 1995 | $17,994.767 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
 Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
 Rogers Corporation
ROG
|
$1.84 B |
9.797 M
|
USA
|
 Santander
SAN
|
$74.60 B |
0.609 B
|
Spain
|
 GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
 AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
 Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
 AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
| Market Cap | = | REC.MI Stock Price | * | REC.MI Shares Outstanding |
| = | $58.10 | * | 0.21 B | |
| = | $11.98 B |